OGEN Annual EBIT
-$20.63 M
-$6.35 M-44.50%
31 December 2023
Summary:
As of January 21, 2025, OGEN annual earnings before interest & taxes is -$20.63 million, with the most recent change of -$6.35 million (-44.50%) on December 31, 2023. During the last 3 years, it has risen by +$5.79 million (+21.93%). OGEN annual EBIT is now -1136.52% below its all-time high of -$1.66 million.OGEN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN Quarterly EBIT
-$2.45 M
-$149.60 K-6.50%
30 September 2024
Summary:
As of January 21, 2025, OGEN quarterly earnings before interest & taxes is -$2.45 million, with the most recent change of -$149.60 thousand (-6.50%) on September 30, 2024. Over the past year, it has increased by +$10.28 million (+80.74%). OGEN quarterly EBIT is now -379.02% below its all-time high of $879.10 thousand, reached on March 31, 2005.OGEN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN TTM EBIT
-$19.94 M
-$454.20 K-2.33%
30 September 2024
Summary:
As of January 21, 2025, OGEN TTM earnings before interest & taxes is -$19.94 million, with the most recent change of -$454.20 thousand (-2.33%) on September 30, 2024. Over the past year, it has increased by +$690.00 thousand (+3.35%). OGEN TTM EBIT is now -9488.79% below its all-time high of -$207.90 thousand, reached on March 31, 2003.OGEN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.5% | +80.7% | +3.4% |
| 3 y3 years | +21.9% | +80.7% | +3.4% |
| 5 y5 years | -108.2% | +80.7% | +3.4% |
OGEN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.5% | at low | -22.7% | +80.7% | -97.0% | +3.4% |
| 5 y | 5-year | -44.5% | +21.9% | -22.7% | +80.7% | -97.0% | +24.6% |
| alltime | all time | -1136.5% | +21.9% | -379.0% | +80.7% | -9488.8% | +24.6% |
Oragenics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.45 M(+6.5%) | -$19.94 M(+2.3%) |
| June 2024 | - | -$2.30 M(-5.7%) | -$19.48 M(-3.7%) |
| Mar 2024 | - | -$2.44 M(-80.8%) | -$20.23 M(-1.9%) |
| Dec 2023 | -$20.63 M(+44.5%) | -$12.74 M(+537.2%) | -$20.63 M(+103.8%) |
| Sept 2023 | - | -$2.00 M(-34.5%) | -$10.12 M(-15.6%) |
| June 2023 | - | -$3.05 M(+7.3%) | -$11.99 M(-4.3%) |
| Mar 2023 | - | -$2.84 M(+27.3%) | -$12.53 M(-12.2%) |
| Dec 2022 | -$14.27 M(-9.1%) | -$2.23 M(-42.3%) | -$14.27 M(-0.4%) |
| Sept 2022 | - | -$3.86 M(+7.7%) | -$14.33 M(-3.4%) |
| June 2022 | - | -$3.59 M(-21.8%) | -$14.84 M(-1.5%) |
| Mar 2022 | - | -$4.59 M(+100.6%) | -$15.07 M(-4.0%) |
| Dec 2021 | -$15.70 M(-40.6%) | -$2.29 M(-47.7%) | -$15.70 M(-11.9%) |
| Sept 2021 | - | -$4.38 M(+14.7%) | -$17.81 M(-0.6%) |
| June 2021 | - | -$3.81 M(-26.9%) | -$17.93 M(-32.2%) |
| Mar 2021 | - | -$5.22 M(+18.4%) | -$26.45 M(+0.1%) |
| Dec 2020 | -$26.42 M(+69.8%) | -$4.40 M(-2.0%) | -$26.42 M(+3.2%) |
| Sept 2020 | - | -$4.49 M(-63.6%) | -$25.61 M(+2.6%) |
| June 2020 | - | -$12.34 M(+137.9%) | -$24.95 M(+43.2%) |
| Mar 2020 | - | -$5.19 M(+44.3%) | -$17.42 M(+12.0%) |
| Dec 2019 | -$15.56 M(+57.0%) | -$3.59 M(-6.2%) | -$15.56 M(+5.7%) |
| Sept 2019 | - | -$3.83 M(-20.2%) | -$14.72 M(+7.9%) |
| June 2019 | - | -$4.81 M(+44.6%) | -$13.64 M(+22.7%) |
| Mar 2019 | - | -$3.32 M(+20.7%) | -$11.11 M(+12.2%) |
| Dec 2018 | -$9.91 M(+52.1%) | -$2.75 M(-0.1%) | -$9.91 M(+15.7%) |
| Sept 2018 | - | -$2.76 M(+20.8%) | -$8.56 M(+10.2%) |
| June 2018 | - | -$2.28 M(+7.6%) | -$7.77 M(+16.8%) |
| Mar 2018 | - | -$2.12 M(+50.4%) | -$6.65 M(+2.1%) |
| Dec 2017 | -$6.52 M(-23.3%) | -$1.41 M(-28.2%) | -$6.52 M(-16.4%) |
| Sept 2017 | - | -$1.96 M(+68.6%) | -$7.79 M(-0.5%) |
| June 2017 | - | -$1.16 M(-41.3%) | -$7.83 M(-6.8%) |
| Mar 2017 | - | -$1.98 M(-26.1%) | -$8.40 M(-1.1%) |
| Dec 2016 | -$8.49 M(-27.8%) | -$2.68 M(+33.9%) | -$8.49 M(+6.1%) |
| Sept 2016 | - | -$2.00 M(+15.7%) | -$8.00 M(+1.8%) |
| June 2016 | - | -$1.73 M(-16.4%) | -$7.86 M(-37.0%) |
| Mar 2016 | - | -$2.07 M(-5.5%) | -$12.47 M(+6.7%) |
| Dec 2015 | -$11.76 M(+103.3%) | -$2.19 M(+17.9%) | -$11.68 M(+9.1%) |
| Sept 2015 | - | -$1.86 M(-70.7%) | -$10.71 M(+8.4%) |
| June 2015 | - | -$6.34 M(+390.6%) | -$9.88 M(+81.7%) |
| Mar 2015 | - | -$1.29 M(+5.7%) | -$5.44 M(-6.0%) |
| Dec 2014 | -$5.79 M(-64.0%) | -$1.22 M(+18.9%) | -$5.79 M(-24.2%) |
| Sept 2014 | - | -$1.03 M(-45.7%) | -$7.63 M(-52.1%) |
| June 2014 | - | -$1.89 M(+15.5%) | -$15.92 M(-1.1%) |
| Mar 2014 | - | -$1.64 M(-46.5%) | -$16.10 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$16.05 M(+29.1%) | -$3.07 M(-67.1%) | -$16.05 M(+7.2%) |
| Sept 2013 | - | -$9.32 M(+349.7%) | -$14.97 M(+93.2%) |
| June 2013 | - | -$2.07 M(+30.5%) | -$7.75 M(-38.2%) |
| Mar 2013 | - | -$1.59 M(-20.1%) | -$12.55 M(+0.9%) |
| Dec 2012 | -$12.43 M(+69.3%) | -$1.99 M(-5.3%) | -$12.43 M(+1.4%) |
| Sept 2012 | - | -$2.10 M(-69.4%) | -$12.26 M(+3.3%) |
| June 2012 | - | -$6.87 M(+364.5%) | -$11.87 M(+62.4%) |
| Mar 2012 | - | -$1.48 M(-18.5%) | -$7.31 M(-0.5%) |
| Dec 2011 | -$7.35 M(-13.6%) | -$1.82 M(+6.1%) | -$7.35 M(-12.6%) |
| Sept 2011 | - | -$1.71 M(-25.8%) | -$8.41 M(-1.9%) |
| June 2011 | - | -$2.31 M(+52.2%) | -$8.57 M(+3.6%) |
| Mar 2011 | - | -$1.52 M(-47.3%) | -$8.27 M(-2.7%) |
| Dec 2010 | -$8.50 M(+55.3%) | -$2.88 M(+53.8%) | -$8.50 M(+24.3%) |
| Sept 2010 | - | -$1.87 M(-6.9%) | -$6.84 M(+7.2%) |
| June 2010 | - | -$2.01 M(+14.9%) | -$6.38 M(+21.8%) |
| Mar 2010 | - | -$1.75 M(+44.0%) | -$5.24 M(-4.2%) |
| Dec 2009 | -$5.48 M(-8.9%) | -$1.21 M(-14.0%) | -$5.47 M(-24.0%) |
| Sept 2009 | - | -$1.41 M(+62.7%) | -$7.21 M(+3.7%) |
| June 2009 | - | -$868.10 K(-56.2%) | -$6.95 M(-3.4%) |
| Mar 2009 | - | -$1.98 M(-32.8%) | -$7.19 M(+19.6%) |
| Dec 2008 | -$6.01 M(+160.1%) | -$2.95 M(+155.4%) | -$6.01 M(+61.2%) |
| Sept 2008 | - | -$1.15 M(+3.7%) | -$3.73 M(+21.4%) |
| June 2008 | - | -$1.11 M(+38.8%) | -$3.07 M(+20.2%) |
| Mar 2008 | - | -$801.10 K(+20.6%) | -$2.56 M(+10.8%) |
| Dec 2007 | -$2.31 M(-21.9%) | -$664.00 K(+34.0%) | -$2.31 M(-2.7%) |
| Sept 2007 | - | -$495.70 K(-16.9%) | -$2.37 M(-3.0%) |
| June 2007 | - | -$596.30 K(+8.2%) | -$2.44 M(-7.8%) |
| Mar 2007 | - | -$551.00 K(-24.2%) | -$2.65 M(-10.6%) |
| Dec 2006 | -$2.96 M(-9.3%) | -$726.90 K(+28.0%) | -$2.96 M(-1.1%) |
| Sept 2006 | - | -$568.00 K(-29.2%) | -$2.99 M(-5.7%) |
| June 2006 | - | -$801.80 K(-7.3%) | -$3.18 M(-2.3%) |
| Mar 2006 | - | -$865.10 K(+13.8%) | -$3.25 M(+115.8%) |
| Dec 2005 | -$3.26 M(+4.5%) | -$760.00 K(+1.3%) | -$1.51 M(-25.5%) |
| Sept 2005 | - | -$750.00 K(-14.3%) | -$2.02 M(+6.5%) |
| June 2005 | - | -$875.00 K(-199.5%) | -$1.90 M(+11.5%) |
| Mar 2005 | - | $879.10 K(-169.0%) | -$1.70 M(-16.4%) |
| Dec 2004 | -$3.12 M(+87.3%) | -$1.27 M(+103.3%) | -$2.04 M(+46.4%) |
| Sept 2004 | - | -$626.90 K(-7.7%) | -$1.39 M(+19.7%) |
| June 2004 | - | -$679.00 K(-224.7%) | -$1.16 M(+26.9%) |
| Mar 2004 | - | $544.50 K(-186.5%) | -$915.50 K(-45.1%) |
| Dec 2003 | -$1.67 M | -$629.20 K(+57.9%) | -$1.67 M(+60.6%) |
| Sept 2003 | - | -$398.40 K(-7.9%) | -$1.04 M(+62.2%) |
| June 2003 | - | -$432.40 K(+108.0%) | -$640.30 K(+208.0%) |
| Mar 2003 | - | -$207.90 K | -$207.90 K |
FAQ
- What is Oragenics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Oragenics?
- What is Oragenics annual EBIT year-on-year change?
- What is Oragenics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Oragenics?
- What is Oragenics quarterly EBIT year-on-year change?
- What is Oragenics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Oragenics?
- What is Oragenics TTM EBIT year-on-year change?
What is Oragenics annual earnings before interest & taxes?
The current annual EBIT of OGEN is -$20.63 M
What is the all time high annual EBIT for Oragenics?
Oragenics all-time high annual earnings before interest & taxes is -$1.66 M
What is Oragenics annual EBIT year-on-year change?
Over the past year, OGEN annual earnings before interest & taxes has changed by -$6.35 M (-44.50%)
What is Oragenics quarterly earnings before interest & taxes?
The current quarterly EBIT of OGEN is -$2.45 M
What is the all time high quarterly EBIT for Oragenics?
Oragenics all-time high quarterly earnings before interest & taxes is $879.10 K
What is Oragenics quarterly EBIT year-on-year change?
Over the past year, OGEN quarterly earnings before interest & taxes has changed by +$10.28 M (+80.74%)
What is Oragenics TTM earnings before interest & taxes?
The current TTM EBIT of OGEN is -$19.94 M
What is the all time high TTM EBIT for Oragenics?
Oragenics all-time high TTM earnings before interest & taxes is -$207.90 K
What is Oragenics TTM EBIT year-on-year change?
Over the past year, OGEN TTM earnings before interest & taxes has changed by +$690.00 K (+3.35%)